Google Screened

Zantac Recalled Due to Potential Cancer-Causing Elements

Philadelphia products liability lawyers protect individuals harmed by defective drugs like Zantac.In September, the popular heartburn medication Zantac was recalled due to the presence of potentially cancer-causing elements. Products like Zantac contain N-nitrosodimethylamine (NDMA), which may cause cancer for users of the drug. Many heartburn medications, also known as ranitidine products, may contain the element, but the Food and Drug Administration (FDA) cannot definitively state if the amount contained in the drug is a lethal health risk. The levels found in preliminary tests by the FDA may be no more dangerous than the meager amount found in various foods. The question remains if the amount found in numerous medications meant to relieve heartburn, both over the counter or prescription, poses a significant risk of developing cancer.

Origination of Cancer-Causing Element

According to the Environmental Protection Agency, the origination of the cancer-causing element NDMA stems from diverse processes and reactions. During the manufacturing process of the medications, NDMA may inadvertently result from certain chemical reactions. On the other hand, the element naturally occurs in the environment and is found in several items, including water and smoked and cured meats, as well as shampoos and cigarette smoke. Some reports claim that when a consumer ingests the medication, NDMA forms through metabolism.

Drug Recalls versus Drug Suspensions

Not every manufacturer or retailer of heartburn medication made the decision to recall the product. The parent company Sanofi, which manufactures Zantac and related heartburn medications, initiated a voluntary recall of the drug in mid-October. The Novartis Group, which produces Sandoz, also recalled their product once their preliminary tests showed inconsistencies. Apotex, which produces the drug for national discount retailers, recalled their versions. At the end of September, CVS suspended sales of Zantac, as well as their store brand of rantidine products. They informed customers who bought the medications that they were eligible for a full refund but never warned them not to take the drugs. As of October 28, the FDA stated that three other pharmaceutical companies decided to recall the rantidine medications.

Decision to Stop Taking the Drug

Despite the recall, the FDA does not necessarily recommend that users stop using it. The initial investigations did not yield enough evidence to support that the drugs may definitively cause cancer. Individuals who wish to use an over the counter medication to relieve heartburn may choose alternative remedies. Any individual using prescription or over the counter medications for this purpose should discuss the matter with their doctor who will assist them in finding a comparable medication.

Philadelphia Products Liability Lawyers at McCann Dillon Jaffe & Lamb, LLC Protect Individuals Harmed by Defective Drugs

Time and further investigation by the FDA will tell if heartburn medications such as Zantac pose a definitive threat to patients who take the drug. If you or a loved one developed health complications from a defective drug, our Philadelphia products liability lawyers at McCann Dillon Jaffe & Lamb, LLC will ensure that you receive the compensation you deserve. Call us at 215-569-8488 or contact us online to schedule a free consultation. Located in Philadelphia, Abington, and Media, Pennsylvania; Wilmington, Delaware; and Haddonfield, New Jersey, we represent clients throughout the surrounding areas.